Insulet | PODD - 销售和管理费用



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.17B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


销售和管理费用 更改 日
Abbott USD 3.6B 330M 2026-06
Align Technology USD 462.67M 2.67M 2026-06
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cardinal Health USD 1.62B 115M 2026-06
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Solventum Corp USD 927M 144M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
West Pharmaceutical Services USD 117.6M 18.1M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06